Overexpression of miR-9-3p in vitro downregulated the RNA and protein expression of HBGF-5, leading to reduced cell viability and proliferation and the decreased expression of ERK1/2, which suggests that miR-9-3p may be a potential therapeutic target for HCC [67]. The gene discussed is FGF5; the disease is hepatocellular carcinoma.